Navigation Links
Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
Date:3/5/2009

al corticosteroids are a mainstay in the treatment of atopic dermatitis. Now, newer formulations of topical corticosteroids in gels, foams and oils, which have undergone specific safety and efficacy testing, have been approved for use in younger patients -- including infants as young as three months of age. The products that are approved by the U.S. Food and Drug Administration (FDA) for this age group to treat atopic dermatitis and eczema include fluocinolone acetonide, topical oil 0.01%, desonide gel 0.05% and desonide foam 0.05%.

Dr. Eichenfield noted that some patients have expressed concern about the cost of treatments. Since major pharmacy retailers are promoting generic drug programs, patients may find a more cost-effective therapy for managing chronic atopic dermatitis.

"The newer approved formulations may cost more compared to the generic medications, so it is important for patients to discuss generic options with their dermatologist," said Dr. Eichenfield.

Topical Calcineurin Inhibitors

Another category of atopic dermatitis therapies used to suppress inflammation of the skin is topical calcineurin inhibitors, which includes the FDA-approved tacrolimus ointment and pimecrolimus cream. Recently, several new studies have examined whether the intermittent use of topical calcineurin inhibitors can effectively control atopic dermatitis. In patients whose atopic dermatitis was initially controlled with the application of topical corticosteroids or tacrolimus ointment, applying topical calcineurin inhibitors intermittently was effective in maintaining control of flare-ups.

"Studies have shown that topical calcineurin inhibitors can be very helpful in a variety of atopic dermatitis treatment regimens," said Dr. Eichenfield. "For instance, these recent studies demonstrate that applying topical tacrolimus ointment two to three times per week successfully controlled the cond
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
2. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
3. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
4. Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
7. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
8. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
9. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
10. Vital Therapies Announces Presentation of ELAD(R) Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
11. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... YORK , 22 de mayo de ... DPRX ), una compañía farmacéutica de ... comercialización de Locilex® (pexiganan cream 0.8%), y ... una presentación de póster destacando el diseño ... 3 de la Compañía que evalúan Locilex®, ...
(Date:5/22/2015)... N.C. , May 22, 2015  Effective ... to pharmaceutical brand recognition and success. ... conducted a study to provide pharmaceutical and biotech ... investment (FTEs and budget) that are being channeled ... and biotech marketing managers can utilize this report ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... and Chicago To Launch,Collaborative Initiative, NEW YORK, ... speed,treatment and cures for pediatric brain tumors and ... the initial phase of a tissue,bank consortium designed ... and cures for these types of cancer, where ...
... Study to Evaluate Preventive Treatment of ... Life Threatening Vulnerable Plaques, ROTTERDAM, Netherlands and DOYLESTOWN, ... Professor Patrick W. Serruys,successfully placed a vProtect(TM) Luminal Shield ... 64-year-old man at Erasmus Medical,Center in Rotterdam. This case ...
Cached Medicine Technology:Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research 2Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research 3Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 2Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 3
(Date:5/25/2015)... Iowa (PRWEB) May 25, 2015 ... Excellence awards for design of the wastewater ... City, Iowa.    The project received a National Recognition Award from ... Honor Award from ACEC – Iowa. Competitions held ... achievements. , The $50.2 million expansion is Iowa City’s ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 ProDrop Light Show ... own VJ neon light backdrops with a click of a mouse. ... and much more all within Final Cut Pro X. , ProDrop ... such as drop zones, kaleidoscope and much more leaving infinite possibilities ... Show drop zones and text presets, users can apply their ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 After the ... the radical science-based human wellness company Trivedi Master ... event from their world-class series titled, “Consciousness is Power.” ... on June 13, 2015 at the routinely allotted time ... The event will be made available to the public ...
(Date:5/25/2015)... White Plains, NY (PRWEB) May 25, 2015 ... LEED AP, principal of PBDW Architects in New York City, ... which is part of the hospital’s ongoing Legacy Lobby Lecture ... campus in White Plains. White is the great grandson of ... firm responsible for the design of Burke’s campus 100 years ...
(Date:5/24/2015)... Kong (PRWEB) May 25, 2015 Pacific Prime has ... three part report looking at the cost of individual international ... Destinations, Article 2 looks at the cost of health insurance in ... , Focusing on, Hong Kong , ... the UAE , the UK ...
Breaking Medicine News(10 mins):Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2
... study of sexual risk behaviors within long-term couples in ... much risk in their sexual behavior when they know ... as when they know their partner is already infected. ... antiretroviral therapy and in intensive counseling do engage in ...
... Boston University School of Medicine (BUSM) have discovered that ... have the propensity to become autoantigens. In a companion ... with dead cells and that the resulting DSautoantigen complexes ... in-vitro and in mouse models. These findings, which appear ...
... Slone Epidemiology Center, in collaboration with the Centers for ... Public Health, have reported widespread and increasing medication use ... in the American Journal of Obstetrics and Gynecology ... status, maternal age, race/ethnicity and state of residence. ...
... PA April 22, 2011 - Sanofi Pasteur, the ... NYSE: SNY), announced today that the U.S. Food and ... indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups ... Vaccine), to include a two-dose schedule for infants and ...
... (HealthDay News) -- While it may be true that beauty ... model helps reveal what,s behind peoples, ideas of facial attractiveness. ... "average" faces and those who fit the conventional notion of ... "femininity" in women. But psychologists Christopher P. Said of New ...
... American Society of Pediatric Otolaryngology (ASPO) will hold its ... 2011 Combined Otolaryngology Spring Meetings (COSM) - a joint ... During the ASPO meeting, hundreds of pieces of new ... will be presented focusing on children,s ear, nose, and ...
Cached Medicine News:Health News:Fighting HIV in South Africa should focus on couples, study finds 2Health News:Fighting HIV in South Africa should focus on couples, study finds 3Health News:Researchers identify novel pathophysiologic mechanism responsible for autoimmunity 2Health News:Researchers report widespread use of medications among pregnant women 2Health News:Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants 2Health News:What Makes a Face Appealing to the Opposite Sex? 2Health News:Scientific session and new research highlights from the American Society of Pediatric Otolaryngology Meeting 2
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
... DW4 liquid handling system from Molecular Devices ... in one instrument. The system handles a ... plate washing96-, 384- and 1536-welland is the ... DW4 has been optimized to dispense from ...
... available to handle multiple assays: ... Embla 384 Cell washer has ... optimized to avoid cell disturbance. ... and have been integrated with ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
Medicine Products: